A randomized trial of computer-delivered brief intervention and low-intensity contingency management for smoking during pregnancy

• Published in: Nicotine & tobacco research Vol. 14; no. 3; p. 351
• Main Authors: Ondersma, Steven J, Svikis, Dace S, Lam, Phebe K, Connors-Burge, Veronica S, Ledgerwood, David M, Hopper, John A
• Format: Journal Article
• Language: English
• Published: England 01.03.2012
• Subjects: Adolescent; Adult; Female; Humans; Motivation; Odds Ratio; Patient Compliance; Patient Education as Topic - methods; Pregnancy; Prenatal Care - methods; Smoking Cessation - methods; Smoking Prevention
• ISSN: 1469-994X
• DOI: 10.1093/ntr/ntr221

Implementation of evidence-based interventions for smoking during pregnancy is challenging. We developed 2 highly replicable interventions for smoking during pregnancy: (a) a computer-delivered 5As-based brief intervention (CD-5As) and (b) a computer-assisted, simplified, and low-intensity contingency management (CM-Lite). A sample of 110 primarily Black pregnant women reporting smoking in the past week were recruited from prenatal care clinics and randomly assigned to CD-5As (n = 26), CM-Lite (n = 28), CD-5As plus CM-Lite (n = 30), or treatment as usual (n = 26). Self-report of smoking, urine cotinine, and breath CO were measured 10 weeks following randomization. Participants rated both interventions highly (e.g., 87.5% of CD-5As participants reported increases in likelihood of quitting), but most CM-Lite participants did not initiate reinforcement sessions and did not show increased abstinence. CD-5As led to increased abstinence as measured by cotinine (43.5% cotinine negative vs. 17.4%; odds ratio [OR] = 10.1, p = .02) but not for CO-confirmed 7-day point prevalence (30.4% abstinent vs. 8.7%; OR = 5.7, p = .06). Collapsing across CM-Lite status, participants receiving the CD-5As intervention were more likely to talk to a doctor or nurse about their smoking (60.5% vs. 30.8%; OR = 3.0, p = .02). Low-intensity participant-initiated CM did not affect smoking in this sample, but the CD-5As intervention was successful in increasing abstinence during pregnancy. Further research should seek to replicate these results in larger and more diverse samples. Should CD-5As continue to prove efficacious, it could greatly increase the proportion of pregnant smokers who receive an evidence-based brief intervention.